Where was cialis in
In October 2007, the FDA announced that the labeling for all PDE5 inhibitors, including tadalafil, requires a more prominent warning of the potential risk of sudden hearing where was cialis in as the result of postmarketing reports of temporary deafness associated with use of PDE5 inhibitors. Ninety-two percent had restored sexual ability after three months.… Read More »